Synagistics Limited — Board/Management Information 2020

Dec 31, 2020

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement , make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [103 x 112] intentionally omitted <==

WEALTHKING INVESTMENTS LIMITED

華 科 資 本 有 限 公 司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 1140)

SUPPLEMENTAL ANNOUNCEMENT OF

CHANGE OF CHIEF EXECUTIVE OFFICER

Reference is made to the announcement published by Wealthking Investments Limited (the “Company”) on 16 December 2020 in relation to Change of Chief Executive Officer and others (the “Announcement”). Unless otherwise stated, the capitalized terms used herein shall have the same meanings as those defined in the Announcement.

The Board of the Company hereby makes the following supplemental disclosure in respect of the roles and responsibilities of the Chief Executive Officer:

ROLES AND RESPONSIBILITIES OF THE CHIEF EXECUTIVE OFFICER

• Creating the organization and managing the day-to-day operation.

• Overseeing the day-to-day running in accordance with the business plans and within the budgets approved by the Board.

• Organizing the implementation of the strategies and policies as approved by the Board and its committees.

• Ensuring that the board is alerted to sensitive or risk issues affecting the Company.

• Evaluating the work of other senior management persons.

• Ensuring the Company maintains high social responsibility.

• Communicating, on behalf of the Company, with stakeholders and the public.

• Promoting the highest standards of integrity, probity and corporate governance.

By Order of the Board of

Wealthking Investments Limited

Liu Zhiwei

Executive Director and Chairman

Hong Kong, 31 December 2020

As at the date of this announcement, the Board comprises one executive Director, namely, Dr. Liu Zhiwei; and four independent non-executive Directors, namely, Professor He Jia, Mr. Wang Xiaojun, Mr. Chen Yumin and Dr.Fu Weigang.